CRTAM anticorps (AA 31-130) (FITC)

N° du produit ABIN1397131

Détail du produit anti-CRTAM anticorps (FITC)

Antigène: CRTAM (Cytotoxic and Regulatory T Cell Molecule (CRTAM))

Épitope: AA 31-130

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CRTAM est conjugé à/à la FITC

Application: Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris

Homologie: Rat,Pig,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CRTAM

Isotype: IgG

Information d'application

Indications d'application: FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CRTAM

Antigène: CRTAM (Cytotoxic and Regulatory T Cell Molecule (CRTAM))

Autre désignation: CRTAM (CRTAM Produits)

Synonymes: anticorps TAD, anticorps cTADS, anticorps MGC82176, anticorps CRTAM, anticorps CD355, anticorps cytotoxic and regulatory T-cell molecule, anticorps cytotoxic and regulatory T-cell molecule L homeolog, anticorps cytotoxic and regulatory T cell molecule, anticorps CRTAM, anticorps crtam.L, anticorps Crtam

Sujet:

Synonyms: CD355, Cytotoxic and regulatory T-cell molecule, Class-I MHC-restricted T-cell-associated molecule, CRTAM

Background: Interaction with CADM1 promotes natural killer (NK) cell cytotoxicity and interferon-gamma (IFN-gamma) secretion by CD8+ cells in vitro as well as NK cell-mediated rejection of tumors expressing CADM3 in vivo.

ID gène: 56253

UniProt: O95727

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation